Recent evidence from pressure overload-induced heart failure models indicates that pharmacological agents such as carnosol not only prevent ventricular arrhythmias but also mitigate adverse remodeling by modulating downstream targets of Akt, including Sirt1 and GSK-3β [53]. This evidence concerns the gene AKT1 and heart failure.